Try our Advanced Search for more refined results
Health
Health Law360 provides breaking legal news and analysis on the health care industry. Coverage includes litigation, policy developments, and corporate deals involving health care services companies such as hospitals, health insurers, physicians groups, and medical suppliers.
Sign up for a 7-day FREE trial today!
Latest News in Health
-
September 26, 2025
Meta Set To Appeal Flo Privacy Verdict As Users Seek Billions
Meta is gearing up to appeal a California federal jury verdict that found it liable for using a data analytics tool to illegally retrieve sensitive health data from users of the popular menstrual tracking app Flo, the company disclosed in a posttrial filing in which the plaintiffs separately asked the court to award statutory damages that could reach the billions.
-
September 26, 2025
EssilorLuxottica Beats Antitrust Suit, Buyers Get 1 Last Shot
A New York federal judge on Friday dismissed two proposed class actions in a consolidated suit that accuses eyewear EssilorLuxottica SA of monopolizing the U.S. consumer eyewear market, saying that direct and indirect purchasers offered an "implausible and contrived definition" of an asserted premium eyewear market.
-
September 26, 2025
States Sue HHS For Order Erasing Gender Ideology In Sex Ed
More than a dozen state attorneys general sued the U.S. Department of Health and Human Services in Oregon federal court Friday, accusing it of violating the Administrative Procedure Act by threatening to revoke grant funding for teen sexual health education unless they eliminate language concerning "gender ideology" from their program materials.
-
September 26, 2025
Semler Scientific, Bard To Pay $37M To End FCA Claims
The Department of Justice announced on Friday that two companies have agreed to pay nearly $37 million to resolve claims that they knowingly recommended healthcare providers submit erroneous Medicare claims for tests for diagnosing artery disease.
-
September 26, 2025
Judge Criticizes Push For Harsher Sentence In CytoDyn Case
A Maryland judge on Friday blasted federal prosecutors for seeking an enhanced sentence for a former biotech executive convicted of fraud for his role in the CytoDyn stock inflation scheme, saying the government wanted a harsher sentence for allegations he was already acquitted of at trial.

Areas of Coverage
- AGENCIES
- U.S. Department of Health and Human Services
- Centers for Medicare and Medicaid Services
- State and international health care regulators
- POLICY & REGULATION
- Affordable Care Act
- Health Insurance Portability and Accountability Act
- Patient鈥檚 Bill of Rights
- Stark Law
- Consumer protection controls
- Tax-related issues
- Health care lobbying
- State and international health care legislation and regulation
- ENFORCEMENT
- Health care fraud investigations
- Merger reviews
- LITIGATION
- Medical malpractice and liability suits
- Mass torts
- Health care fraud disputes
- Insurance coverage suits
- Reimbursement disputes
- Whistleblower and anti-corruption compliance suits
- Antitrust suits
- Breach of contract suits
- Labor and employment issues
- Shareholder disputes
- Bankruptcy proceedings
- TRANSACTIONS
- Mergers, acquisitions, and joint ventures
- Health care project finance and real estate deals
- PROFILES
- Personnel moves
- Profiles of health attorneys
Readership
- Health care lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the health care services industry
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals